Differential microRNA expression analyses across two brain regions in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2158-3188

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Differential microRNA expression analyses across two brain regions in Alzheimer’s disease ; volume:12 ; number:1 ; day:29 ; month:8 ; year:2022 ; pages:1-9 ; date:12.2022
Translational Psychiatry ; 12, Heft 1 (29.8.2022), 1-9, 12.2022

Creator: Dobricic, Valerija
Schilling, Marcel
Schulz, Jessica
Zhu, Ling-Shuang
Zhou, Chao-Wen
Fuß, Janina
Franzenburg, Sören
Zhu, Ling-Qiang
Parkkinen, Laura
Lill, Christina M.
Bertram, Lars

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41398-022-02108-4

URN: urn:nbn:de:101:1-2022111621090732307009

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Dobricic, Valerija
Schilling, Marcel
Schulz, Jessica
Zhu, Ling-Shuang
Zhou, Chao-Wen
Fuß, Janina
Franzenburg, Sören
Zhu, Ling-Qiang
Parkkinen, Laura
Lill, Christina M.
Bertram, Lars
SpringerLink (Online service)

Other Objects (12)

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Differential microRNA expression analyses across two brain regions in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries

Decoding Alzheimer’s in the age of genome-wide analyses

Alzheimer’s disease rewires gene coexpression networks coupling different brain regions

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

The Role of Futility Analyses in Alzheimer’s Disease Clinical Trials

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease

CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Related objects

Reset password